Clinical Trial Update: A Study of CIN-107 in Adults With Primary Aldosteronism [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of CIN-107 in adults with primary aldosteronism completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism
• Hyperaldosteronism

Drugs mentioned

• CIN-107

Snippet

Sponsor: AstraZeneca | Conditions: Primary Aldosteronism, Hyperaldosteronism | Phase 2 | Status: COMPLETED | Results posted: 2026-03-03